Adoptive T-cell therapy against cancer using tumor-infiltrating lymphocytes (TIL) and gene engineered T cells
Publication Title
World CCA Day Webinar: Immunotherapy Innovations: Expert Insights and a Survivor’s Journey; 2025 February 20
Document Type
Presentation
Publication Date
2-20-2025
Keywords
oregon; chiles; portland
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
